| Donald Jf Kammerer, MD | |
|
404 W Fountain St, Albert Lea, MN 56007-2437 | |
| (507) 373-2384 | |
| Not Available |
| Full Name | Donald Jf Kammerer |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 404 W Fountain St, Albert Lea, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497735534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 27149 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald Jf Kammerer, MD 1405 Lakewood Ave, Albert Lea, MN 56007-2248 Ph: (507) 373-4743 | Donald Jf Kammerer, MD 404 W Fountain St, Albert Lea, MN 56007-2437 Ph: (507) 373-2384 |
News Archive
Viatronix Incorporated, a Stony Brook, New York, based company announced that its V3D-Colon software is used at the National Naval Medical Center where the President's annual physical was done. "Our software is being utilized at several DOD facilities since the landmark Virtual Colonoscopy clinical trial published in the New England Journal of Medicine back in December 2003," said Zaffar Hayat, President of Viatronix Incorporated.
The Chinese government has stopped the gene editing works of Professor He Jiankui calling it unlawful and unethical. Notably Professor Jiankui had recently claimed to have produced the world's first pair of twins who have their genetic codes edited so that they would never be infected with HIV.
The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of the Journal of Bone and Joint Surgery (JBJS).
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.
Most patients experience significant distress after they are diagnosed with cancer. This distress not only erodes quality of life, but can also negatively affect the course of the disease and the patient's ability to tolerate treatment.
› Verified 8 days ago
Edward Reece Shaman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Andrea Vanessa Caraccioli, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Dr. John Halerz Ii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Michael David Ulrich, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Dr. Steven John Schulz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Duard Dewayne Birkhofer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 |